INGN | Inogen, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.67 - 7.33
52 Week Range	6.14 - 13.33
Beta	1.52
Implied Volatility	76.59%
IV Rank	72.50%
Day's Volume	477,749
Average Volume	315,378
Shares Outstanding	26,529,500
Market Cap	180,400,600
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2014-02-14

Valuation
Profitability
Growth
Health
P/E Ratio	-4.47
Forward P/E Ratio	-11.43
EPS	-1.52
1YR Price Target	24.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	834
Country	USA
Website	INGN

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.

INGN's peers: APYX, BSGM, CLPT, SMLR, CODX, CTKB, CTSO, ESTA, HYPR, NPCE, SRDX, LUNG, CVRX, OFIX, AORT, HSKA, KIDS, SGHT, CNMD, ITGR, NUVA, SIBN, VERO, ZIMV

*Chart delayed

Analyzing fundamentals for INGN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see INGN Fundamentals page.

Watching at INGN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INGN Technicals page.